Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis.

It has been suggested that chemotherapy-associated weight gain during treatment for early-stage breast cancer may be transient [ 5 ], but if in fact body composition (i.e., an increase in body-fat percentage) and not just weight is altered during treatment with chemotherapy, the long-term health consequences may be significant even if an individual returns to their pre-chemotherapy weight.

also in 4,095 other papers